agilon health, inc.

AGL

agilon health, inc.

AGL

Insider Sentiment (TTM):

Last Purchase:2026-03-09Last Sale:2023-09-13Shares Purchased (TTM):623,431Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:15,289,726Shares Outstanding:16,599,000Institutional Ownership Pct.:92.11%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Misc Health & Allied Services, NEC

DVA SHC PGNY VMD PARK CCEL

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	140	174	172	171	137	188	148	109	112	108	168	191
Restricted Cash Equivalents Current	72	0	0	0	2	6	6	7	7	7	10	10
Debt Securities Available For Sale Excluding Accru…	91	111	139	156	230	212	245	292	307	381	396	389
Receivables Net Current	900	674	947	1,047	1,240	1,017	1,368	1,437	1,571	942	1,346	1,417
Prepaid Expense And Other Assets Current	118	138	80	78	42	35	45	39	40	43	37	38
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	-	-	-	-	0	-	-
Assets Current	1,321	1,097	1,338	1,453	1,651	1,458	1,812	1,884	2,037	1,480	1,957	2,045
Property Plant And Equipment Net	25	25	26	27	28	28	28	28	28	28	26	24
Intangible Assets Net Excluding Goodwill	62	66	75	66	68	73	73	75	72	64	93	94
Goodwill	-	0	24	24	24	24	24	24	24	24	62	62
Other Assets Noncurrent	96	83	133	143	162	151	154	153	156	145	140	127
Assets	1,505	1,271	1,596	1,713	1,933	1,734	2,091	2,163	2,316	1,741	2,278	2,353
Liabilities And Stockhold…
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	-	-	-	-	0	-	-
Liabilities Current
Liability For Claims And Claims Adjustment Expense	1,055	930	1,059	1,042	1,113	932	1,191	1,098	1,267	738	1,006	1,100
Accounts Payable And Accrued Liabilities Current	202	127	146	172	227	220	218	281	252	239	291	258
Long Term Debt Current	15	19	35	35	35	0	-	9	8	6	5	5
Liabilities Current	1,272	1,076	1,240	1,249	1,375	1,152	1,409	1,387	1,527	977	1,301	1,362
Long Term Debt Noncurrent	15	16	0	0	0	35	35	27	30	32	35	36
Other Liabilities Noncurrent	36	52	50	55	58	76	72	73	71	70	70	75
Liabilities	1,324	1,145	1,290	1,304	1,433	1,263	1,517	1,487	1,628	1,080	1,406	1,473
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	-	-	0	-	-
Stockholders Equity Inclu…
Common Stock Value	0	4	4	4	4	4	4	4	4	4	4	4
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	-	-	0	-	-
Additional Paid In Capital Common Stock	2,110	2,100	2,090	2,083	2,070	2,054	2,052	2,039	2,021	1,987	1,971	1,947
Retained Earnings Accumulated Deficit	-1,929	-1,978	-1,789	-1,679	-1,575	-1,587	-1,481	-1,364	-1,333	-1,327	-1,096	-1,065
Accumulated Other Comprehensive Income Loss Net Of…	0	1	1	1	1	-0	0	-2	-3	-2	-6	-6
Stockholders Equity	181	127	306	409	500	471	575	676	688	662	872	879
Minority Interest	-	-	-	-	-	0	0	-1	-1	-1	-1	-1
Liabilities And Stockholders Equity	1,505	1,271	1,596	1,713	1,933	1,734	2,091	2,163	2,316	1,741	2,278	2,353
Variable Interest Entity Primary Beneficiary	1,060	840	-90	-190	1,380	1,170	-70	-110	1,710	1,070	-80	380
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000
Common Stock Shares Issued	17	17	17	17	17	16	16	16	16	16	16	16
Shares Outstanding	415	415	415	414	413	412	412	411	411	406	406	405

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	231.35%	328.19%	-	-	-	-	-	-	-	-	-	-
2025	-50.22%	-48.21%	-53.81%	-29.48%	-39.94%	-46.56%	-10.08%	0.28%	36.88%	-14.80%	140.40%	553.84%
2024	26.51%	31.33%	38.35%	-34.41%	-39.87%	-58.52%	-25.09%	-31.90%	29.39%	24.79%	10.19%	-32.51%
2023	-22.26%	-33.33%	-27.45%	-9.65%	-3.31%	1.47%	-30.14%	-26.23%	-62.29%	-24.54%	-15.74%	-16.51%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.04	1.02	1.08	1.16	1.20	1.27	1.29	1.36	1.33	1.51	1.50	1.50
Quick Ratio	0.95	0.89	1.01	1.10	1.17	1.23	1.25	1.33	1.31	1.47	1.48	1.47
Working Capital	48.85M	20.21M	98.15M	203.57M	276.02M	305.77M	402.60M	496.70M	510.16M	502.92M	655.32M	682.49M
Leverage & Debt
Debt to Equity	7.29	9.03	4.22	3.19	2.86	2.68	2.64	2.20	2.36	1.63	1.61	1.68
Interest Coverage TTM	-63.01	-69.75	-58.09	-60.44	-47.92	-47.29	-53.35	-38.75	-37.17	-34.87	-19.05	-19.50
Debt Ratio	0.88	0.90	0.81	0.76	0.74	0.73	0.73	0.69	0.70	0.62	0.62	0.63
Efficiency & Turnover
Asset Turnover TTM	3.39	3.95	3.19	3.04	2.82	3.49	2.56	2.34	2.17	2.51	1.75	1.52
Days Sales Outstanding TTM	67.08	52.01	71.80	76.83	85.65	59.01	88.54	98.65	96.61	60.67	99.72	115.90
Receivables Turnover TTM	5.44	7.02	5.08	4.75	4.26	6.19	4.12	3.70	3.78	6.02	3.66	3.15
Per Share Metrics
Diluted EPS TTM	-21.28	-23.63	-18.59	-19.07	-14.65	-15.82	-23.37	-18.15	-17.40	-16.05	-5.48	-5.37
Free Cash Flow Per Share TTM	-3.77	-7.19	-4.97	-4.36	-3.39	-4.32	-9.07	-9.43	-9.68	-10.52	-9.88	-8.78
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-0.44%	-0.76%	0.51%	0.50%	3.15%	3.60%	2.05%	5.38%	6.40%	7.13%	-3.08%	-4.68%
Operating Profit Margin TTM	-7.51%	-7.81%	-6.41%	-6.44%	-5.13%	-4.82%	-6.23%	-4.81%	-4.93%	-5.38%	-3.36%	-3.52%
Net Profit Margin TTM	-6.09%	-6.60%	-5.24%	-5.35%	-4.04%	-4.29%	-6.88%	-5.65%	-5.85%	-6.08%	-2.45%	-2.76%
Growth Metrics
Net Revenue Growth (1Y)	-2.82%	-2.11%	5.21%	11.76%	23.07%	40.41%	54.10%	65.62%	74.48%	80.74%	46.30%	42.00%
Net Income Growth (1Y)	46.53%	50.46%	-19.87%	5.73%	-15.00%	-0.95%	332.71%	238.93%	209.16%	145.73%	-16.93%	-21.49%
EPS Growth (1Y)	45.81%	49.37%	-20.43%	5.07%	-15.82%	-1.44%	326.60%	238.16%	212.34%	145.27%	-15.85%	-22.06%
Valuation Metrics
P/E TTM	-0.37	-0.73	-1.38	-3.02	-7.39	-3.00	-4.20	-9.01	-8.76	-19.54	-81.06	-80.77
P/B TTM	0.72	2.25	1.39	2.33	3.57	1.66	2.81	3.98	3.62	7.76	8.26	8.09
P/S TTM	0.02	0.05	0.07	0.16	0.30	0.13	0.29	0.51	0.51	1.19	1.99	2.23
Market Cap	131.30M	285.22M	426.90M	951.82M	1.79B	780.84M	1.62B	2.69B	2.49B	5.13B	7.21B	7.12B
Enterprise Value	21.34M	146.50M	290.18M	815.35M	1.69B	621.88M	1.50B	2.61B	2.41B	5.06B	7.08B	6.97B
Calculated Values
Free Cash Flow TTM	-62.54M	-119.01M	-82.35M	-72.26M	-55.95M	-71.03M	-149.28M	-155.15M	-158.42M	-172.03M	-160.38M	-144.06M
Net Debt	-109.96M	-138.73M	-136.72M	-136.47M	-102.02M	-158.96M	-118.91M	-80.23M	-81.22M	-75.77M	-129.88M	-143.53M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-09Purchase

Owner: Zamore, Denise

Title: Chief Legal Officer

Shares: 5,535

Price/Share: -

Value: -

Shares Owned: 448,660

Relationship: Officer

Ownership: Direct

2026-03-09Purchase

Owner: Shaker, Benjamin

Title: Chief Markets Officer

Shares: 18,448

Price/Share: -

Value: -

Shares Owned: 1,386,122

Relationship: Officer

Ownership: Direct

2026-03-09Purchase

Owner: Venkatachaliah, Girish

Title: Chief Technology Officer

Shares: 18,448

Price/Share: -

Value: -

Shares Owned: 285,084

Relationship: Officer

Ownership: Direct

2026-03-02Purchase

Owner: Shaker, Benjamin

Title: Chief Markets Officer

Shares: 500,000

Price/Share: $0.60

Value: $300,000.00

Shares Owned: 1,367,674

Relationship: Officer

Ownership: Direct

2025-11-12Purchase

Owner: Wulf, John William

Title: -

Shares: 81,000

Price/Share: $0.63

Value: $51,030.00

Shares Owned: 365,857

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-09	Zamore, Denise	Officer	Chief Legal Officer	Direct	Purchase	5,535	-	-	448,660	4
2026-03-09	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Purchase	18,448	-	-	1,386,122	4
2026-03-09	Venkatachaliah, Girish	Officer	Chief Technology Officer	Direct	Purchase	18,448	-	-	285,084	4
2026-03-02	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Purchase	500,000	0.60	$300,000.00	1,367,674	4
2025-11-12	Wulf, John William	Director	-	Direct	Purchase	81,000	0.63	$51,030.00	365,857	4
2025-03-14	Venkatachaliah, Girish	Officer	Chief Technology Officer	Direct	Purchase	9,429	-	-	158,431	4
2025-03-14	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Purchase	11,786	-	-	461,201	4
2025-03-14	Sell, Steven	Director,Officer	CEO & President	Direct	Purchase	42,426	-	-	370,873	4
2024-12-13	Mcloughlin, Karen	Director	-	Direct	Purchase	25,000	2.20	$55,000.00	73,166	4
2024-12-11	Battaglia, Silvana	Director	-	Direct	Purchase	25,062	2.01	$50,374.62	66,144	4
2024-12-09	Mckenzie, Diana	Director	-	Direct	Purchase	7,500	2.20	$16,500.00	58,819	4
2024-12-05	Wulf, John William	Director	-	Direct	Purchase	45,000	2.18	$98,100.00	206,133	4
2024-09-12	Sell, Steven	Director,Officer	CEO & President	Indirect	Purchase	20,000	3.36	$67,200.00	67,590	4
2024-03-14	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Purchase	274,455	-	-	353,998	4
2024-03-14	Kornitzer, Benjamin	Officer	Chief Med. & Quality Officer	Direct	Purchase	5,434	-	-	63,941	4
2024-03-14	Venkatachaliah, Girish	Officer	Chief Technology Officer	Direct	Purchase	5,434	-	-	41,833	4
2024-03-14	Desai, Veeral	Officer	Chief Strategy & Dev. Officer	Direct	Purchase	11,956	-	-	311,541	4
2024-03-14	Bensley, Timothy	Officer	Chief Financial Officer	Direct	Purchase	14,945	-	-	50,116	4
2023-11-29	Schwaneke, Jeffrey A.	Director	-	Direct	Purchase	22,300	11.22	$250,206.00	31,931	4
2023-11-29	Schwaneke, Jeffrey A.	Officer	Chief Financial Officer	Indirect	Purchase	22,300	11.22	$250,206.00	22,300	4/A
2023-11-21	Sell, Steven	Director,Officer	CEO & President	Indirect	Purchase	44,690	11.14	$497,846.60	47,590	4
2023-09-13	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Sale	18,750	18.00	$337,500.00	79,543	4
2023-09-11	Gertsch, Timothy	Officer	Chief Accounting Officer	Direct	Sale	26,250	18.62	$488,775.00	17,121	4
2023-08-15	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Sale	18,750	18.10	$339,375.00	79,543	4
2023-07-13	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Sale	18,750	16.93	$317,437.50	79,543	4
2023-06-15	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Sale	18,750	18.73	$351,187.50	79,543	4
2023-05-18	Cd&R, Investment Associat…	TenPercentOwner	-	Indirect	Sale	94,173,804	20.80	$1,958,815,123.20	100,000,000	4
2023-05-16	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Sale	25,000	23.14	$578,500.00	79,543	4
2023-05-09	Desai, Veeral	Officer	Chief Strategy & Dev. Officer	Direct	Sale	4,500	26.15	$117,675.00	299,585	4
2023-04-20	Desai, Veeral	Officer	Chief Strategy & Dev. Officer	Direct	Sale	500	26.15	$13,075.00	299,585	4
2023-04-18	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Sale	25,000	28.05	$701,250.00	79,543	4
2023-03-24	Desai, Veeral	Officer	Chief Strategy & Dev. Officer	Direct	Sale	97,290	28.70	$2,792,223.00	276,729	4
2023-03-23	Kornitzer, Benjamin	Officer	Chief Med. & Quality Officer	Direct	Sale	8,094	28.04	$226,955.76	55,426	4
2023-03-16	Desai, Veeral	Officer	Chief Strategy & Dev. Officer	Direct	Sale	60,000	26.09	$1,565,400.00	276,729	4
2023-03-16	Shaker, Benjamin	Officer	Chief Markets Officer	Direct	Sale	25,000	25.36	$634,000.00	60,625	4
2023-03-15	Kornitzer, Benjamin	Officer	Chief Med. & Quality Officer	Direct	Sale	55,000	23.81	$1,309,550.00	55,426	4
2023-03-15	Wulf, John William	Director	-	Direct	Sale	80,000	23.82	$1,905,600.00	123,392	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

92.11%

Inst. Shares: 15,289,726

Shares Outstanding: 16,599,000

2025-12-31

88.51%

Inst. Shares: 14,656,700

Shares Outstanding: 16,558,760

2025-09-30

91.70%

Inst. Shares: 15,202,921

Shares Outstanding: 16,578,600

2025-06-30

95.03%

Inst. Shares: 15,729,908

Shares Outstanding: 16,553,440

2025-03-31

95.67%

Inst. Shares: 15,801,838

Shares Outstanding: 16,517,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	15,289,726	16,599,000	92.11%
2025-12-31	14,656,700	16,558,760	88.51%
2025-09-30	15,202,921	16,578,600	91.70%
2025-06-30	15,729,908	16,553,440	95.03%
2025-03-31	15,801,838	16,517,000	95.67%
2024-12-31	16,445,073	16,438,640	100.04%
2024-09-30	16,969,820	16,463,640	103.07%
2024-06-30	18,045,234	16,450,840	109.69%
2024-03-31	17,475,212	16,357,520	106.83%
2023-12-31	17,102,015	16,356,680	104.56%
2023-09-30	17,021,778	16,231,480	104.87%
2023-06-30	16,626,679	16,413,520	101.30%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

agilon health, inc. (AGL) — SEC Financial Statements & Analysis

agilon health, inc. (AGL) is a services-misc health & allied services, nec company, incorporated in DE. agilon health, inc. trades on NYSE as: AGL. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), agilon health, inc. reported a -2.82% year-over-year revenue growth, a Gross Profit Margin of -0.44% (TTM), a Debt-to-Equity ratio of 7.29x, a Price-to-Sales (P/S) ratio of 0.02x (TTM), a Price-to-Book (P/B) ratio of 0.72 (TTM), at a market cap of $131.30M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -2.82%
Gross Profit Margin TTM: -0.44%
Debt To Equity: 7.29x
P/S TTM: 0.02x
P/B TTM: 0.72
Market Cap: $131.30M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is agilon health, inc. in?

agilon health, inc. (AGL) operates in the Services-Misc Health & Allied Services, NEC industry.

What is AGL's market cap?

agilon health, inc. (AGL) has a market capitalization of $131.30M as of 2026-03-31.

What exchange does AGL trade on?

agilon health, inc. (AGL) trades on the NYSE.

Where is agilon health, inc. incorporated?

agilon health, inc. is incorporated in DE.

agilon health, inc. (AGL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.